(Q66080879)
Statements
A Multi-Center, Open Label, Phase I, Dose Finding and Expansion Study of RO7051790 Administered Orally in Patients With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC) (English)
0 references
20 December 2016
0 references
24 October 2017
0 references
18
0 references
18 year
0 references